Xbiotech Inc. (XBIT) — 10-Q Filings

10-Q Filings (6)

• XBiotech Narrows 9-Month Loss to $18.6M, Cash Dips to $147M — Nov 12, 2025 Risk: medium
  XBiotech Inc. reported a net loss of $6.008 million for the three months ended September 30, 2025, an increase from a net loss of $5.015 million in the same per
• XBiotech Narrows Q2 Loss on Reduced R&D, Cash Reserves at $152.9M — Aug 13, 2025 Risk: medium
  XBiotech Inc. reported a net loss of $1.756 million for the three months ended June 30, 2025, a significant improvement from the $13.006 million net loss in the
• XBiotech Inc. Files Q1 2025 10-Q — May 14, 2025 Risk: medium
  XBiotech Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and business operations for the first quarter of 202
• XBiotech Inc. Files Q3 2024 10-Q Report — Nov 13, 2024 Risk: medium
  XBiotech Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter and the first nine months of
• XBiotech Inc. Files Q2 2024 10-Q — Aug 12, 2024 Risk: medium
  XBiotech Inc. filed its 10-Q for the period ending June 30, 2024. The company, located in Austin, TX, operates in the pharmaceutical preparations sector. Financ
• XBiotech Inc. Files 10-Q for Q1 2024 — May 10, 2024 Risk: medium
  XBiotech Inc. (XBIT) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. XBiotech Inc. filed its 10-Q for the period ending March 31, 2024. The filing

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX